Prevention of febrile neutropenia: use of prophylactic antibiotics
Explore this paper's citation graph
Summary
Fluoroquinolone prophylaxis is well tolerated and cost-effective and should be offered to patients receiving chemotherapy for haematological malignancies and high-dose chemotherapy for solid tumours in which prolonged (>7 days) neutropenia is expected.
- Type
- article
- Published
- 2009-09-01
- Cited by
- 69
- References
- 29
- Access
- Open access
- OpenAlex
- https://openalex.org/W2084280001
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:18267225
Keywords
Medicine, Chemotherapy, Febrile neutropenia, Neutropenia, Levofloxacin
References
- Breast cancer: Improved care through effective management of febrile neutropenia. Foreword.
- Meta-Analysis: Antibiotic Prophylaxis Reduces Mortality in Neutropenic Patients
- Efficacy of oral prophylactic antibiotics in neutropenic afebrile oncology patients: a systematic review of randomised controlled trials.
- Prophylactic G-CSF in patients with early-stage breast cancer: a health economic review
- Impact of effective prevention and management of febrile neutropenia
- Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP‐R, or CNOP chemotherapy for intermediate‐grade non‐Hodgkin lymphoma
- Prevention of febrile neutropenia: use of granulocyte colony-stimulating factors
- The new fluorinated quinolones for antimicrobial prophylaxis in neutropenic cancer patients.
- Management of chemotherapy-associated febrile neutropenia
- First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study.
- Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia
- In vitro Activity of Levofloxacin against Gram-Positive Bacteria
- Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas.
- Bacteremia due to viridans group Streptococci with diminished susceptibility to Levofloxacin among neutropenic patients receiving levofloxacin prophylaxis.
- Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer.
- Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.
- The antibacterial efficacy of levofloxacin and ciprofloxacin against Pseudomonas aeruginosa assessed by combining antibiotic exposure and bacterial susceptibility.
- Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.
- Rational selection of patients for antibacterial prophylaxis after chemotherapy.
- EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours.
Cited by
- Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies.
- Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea
- Management of Infection and Febrile Neutropenia in Patients with Solid Cancer.
- Molecular genetic basis for fluoroquinolone-induced retinal degeneration in cats
- Prophylactic G-CSF in patients with early-stage breast cancer: a health economic review
- Tyrosine Kinase Inhibitors Enhance Ciprofloxacin-Induced Phototoxicity by Inhibiting ABCG2
- Impact of effective prevention and management of febrile neutropenia
- Practical recommendations for hypomethylating agent therapy of patients with myelodysplastic syndromes.
- Clinical Impact of Fluoroquinolone-Resistant Escherichia coli in the Fecal Flora of Hematological Patients with Neutropenia and Levofloxacin Prophylaxis
- Seeking the mechanism responsible for fluoroquinolone photomutagenicity: a pulse radiolysis, steady-state, and laser flash photolysis study.
- Prevention of febrile neutropenia: use of granulocyte colony-stimulating factors
- Incidence of Hospital-Acquired Pneumonia, Bacteraemia and Urinary Tract Infections in Patients with Haematological Malignancies, 2004–2010: A Surveillance-Based Study
- Fluoroquinolone prophylaxis against febrile neutropenia in areas with high fluoroquinolone resistance--an Asian perspective.
- Chemotherapy for early-stage breast cancer: a brief history
- High incidence of febrile neutropenia following adjuvant breast chemotherapy with docetaxel, carboplatin and trastuzumab
- Granulocyte Transfusion Therapy
- Lipegfilgrastim for the prophylaxis and treatment of chemotherapy-induced neutropenia
- Biomarkers for bacteremia and severe sepsis in hematological patients with neutropenic fever: multivariate logistic regression analysis and factor analysis
- Triplet excimers of fluoroquinolones in aqueous media.
- [Results of treatment of acute lymphoblastic leukemia in two cohorts of Mexican patients].
Related papers
- Factor analysis of levofloxacin led phlebitis
- Study on the uptake of levofloxacin by gastric epithelial system cells
- Levofloxacin for febrile neutropenia prophylaxis in acute myeloid leukemia patients associated with reduction in hospital admissions
- Advances in the Treatment of Neutropenia
- Febrile neutropenia in patients with hematological malignancies - definition, diagnosis and management
- Phase I dose-escalation study of the investigational Aurora A kinase (AAK) inhibitor MLN8237 as an enteric-coated tablet (ECT) formulation in patients with nonhematologic malignancies.
- [Efficacy of moxifloxacin (Avelox) in prophylaxis of infection in patients with profound neutropenia].
- Incidence of Febrile Neutropenia in Breast Cancer Patients Treated With Chemotheraphy Protocols From 01.01.2020 to 31.12.2021 in University Clinical Center of Republic of Srpska Banja Luka
- Neutropenia and febrile neutropenia in patients with Hodgkin's lymphoma treated with doxorubicin (Adriamycin), bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy